Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 3.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 001E91 | Kurt Huber [Autriche] ; David R. Jr Holmes [États-Unis] ; Arnoud W. Van T Hof [Pays-Bas] ; Gilles Montalescot [France] ; Philip E. Aylward [Australie] ; G. Amadeo Betriu [Espagne] ; Petr Widimsky [République tchèque] ; Cynthia M. Westerhout [Canada] ; Christopher B. Granger [États-Unis] ; Paul W. Armstrong [Canada] | Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial |
| 002600 | Matthew Sibbald [Canada] ; Andrewt. Yan [Canada] ; WEI HUANG [États-Unis] ; Keith A. A. Fox [Royaume-Uni] ; Joel M. Gore [États-Unis] ; Ph Gabriel. Steg [France] ; Kim A. Eagle [États-Unis] ; David Brieger [Australie] ; Gilles Montalescot [France] ; Shaun G. Goodman [Canada] | Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events |
| 002755 | Harvey D. White [Nouvelle-Zélande] ; Richard Gallo [Canada] ; Marc Cohen [États-Unis] ; Ph. Gabriel Steg [France] ; Philip E. Aylward [Australie] ; Christoph Bode [Allemagne] ; Steve Steinhubl [États-Unis] ; Gilles Montalescot [France] | The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment : Results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial |
| This area was generated with Dilib version V0.6.33. |  |